Immuno-Oncology 360

Imaging in clinical trials has seen tremendous growth as evidenced by the number of trials initiated over the past two decades. Additionally, imaging data is increasingly used as the primary endpoint for some related trials. Put our expertise in drug, device and biologic imaging to work for you. At IO360 Immuno-Oncology clinical trial leaders will cover design trial, clinical operations, and the latest outcomes learned at this event. A wide range of emerging technologies will be covered, including ERT’s presentation on Advanced Imaging Technology which has become a hot topic in the industry.

Can’t make it? Click here to learn how ERT Advanced Imaging Technology can minimize manual errors and bias while maximizing visibility.